1. Published Data Registry
  2. View publication

View publication

↩ Back to all publications
Publication
PropertyValue
Working Groups Hemmer
SubprojectNone
Open AccessOpen Access Yes
Publication TypeJournal Article
Peer ReviewedYes
PMIDPubMed ID 36689214
DOIDOI 10.1001/jamaneurol.2022.5007
Publication Year2023
TitleEfficacy and Safety of Proposed Biosimilar Natalizumab (PB006) in Patients With Relapsing-Remitting Multiple Sclerosis: The Antelope Phase 3 Randomized Clinical Trial.
JournalJAMA neurology
ISSN2168-6149
ESSN2168-6157
URL https://www.ncbi.nlm.nih.gov/pubmed/?term=36689214%5Buid%5D
Pages298-307
Issue3
Volume80
Journal AbbreviationJAMA Neurol
AuthorsHemmer B, Wiendl H, Roth K, Wessels H, Höfler J, Hornuss C, Liedert B, Selmaj K
First AuthorHemmer B
Last AuthorSelmaj K